González-Rueda, S.; GarcÃa-Pérez, O.; Luna-Gutiérrez, M.; Ocampo-GarcÃa, B.; Santos-Cuevas, C.; RamÃrez-Nava, G.; Vargas-Ahumada, J.; AzorÃn-Vega, E.; Ferro-Flores, G.; Meléndez-Alafort, L.
Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study. Pharmaceutics 2024, 16, 1358.
https://doi.org/10.3390/pharmaceutics16111358
AMA Style
González-Rueda S, GarcÃa-Pérez O, Luna-Gutiérrez M, Ocampo-GarcÃa B, Santos-Cuevas C, RamÃrez-Nava G, Vargas-Ahumada J, AzorÃn-Vega E, Ferro-Flores G, Meléndez-Alafort L.
Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study. Pharmaceutics. 2024; 16(11):1358.
https://doi.org/10.3390/pharmaceutics16111358
Chicago/Turabian Style
González-Rueda, SofÃa, Osvaldo GarcÃa-Pérez, Myrna Luna-Gutiérrez, Blanca Ocampo-GarcÃa, Clara Santos-Cuevas, Gerardo RamÃrez-Nava, Joel Vargas-Ahumada, Erika AzorÃn-Vega, Guillermina Ferro-Flores, and Laura Meléndez-Alafort.
2024. "Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study" Pharmaceutics 16, no. 11: 1358.
https://doi.org/10.3390/pharmaceutics16111358
APA Style
González-Rueda, S., GarcÃa-Pérez, O., Luna-Gutiérrez, M., Ocampo-GarcÃa, B., Santos-Cuevas, C., RamÃrez-Nava, G., Vargas-Ahumada, J., AzorÃn-Vega, E., Ferro-Flores, G., & Meléndez-Alafort, L.
(2024). Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study. Pharmaceutics, 16(11), 1358.
https://doi.org/10.3390/pharmaceutics16111358
